L’Oreal says it’s working on a form of bioprinted skin that can actually ‘feel’

L’Oreal says it’s working on a form of bioprinted skin that can actually ‘feel’


L’Oreal says it is working with start-ups and research institutions to bioprint skin that can actually “feel.”

L’Oreal

PARIS, France — French beauty and cosmetics giant L’Oreal is working on a form of synthetically produced skin that it says will one day be able to “feel” like we do.

At the Viva Technology conference in Paris last week, L’Oreal showed off demonstrations of “bioprinting,” technology that can 3D print humanlike skin, in action.

The firm has been using this tech for several years to test new makeups on synthetic skin in its lab rather than animals.

L’Oreal says it ceased testing its products on animals back in 1989, long before it was required by regulation.

Guive Balooch, head of L’Oreal’s tech incubator, describes bioprinting as the “ability to use 3D printing with biology to reconstruct skin in personalized ways adjusting for a fully inclusive set of actual reconstructed skin.”

“This is going to be a revolution, too. We’re doing it internally but also working with external partners as well,” Balooch told CNBC at the firm’s booth at VivaTech.

Orange CEO: AI should reflect different global cultures

This skin technology enables L’Oreal to mimic the diversity of real, human skin, including conditions such as eczema and acne, as well as the ability to tan and heal from injury, L’Oreal said in a statement last week.

L’Oréal isn’t just stopping there, though. The company said it’s also working with startups and research institutions to further develop its bioprinting technology to enable skin that can actually “feel.”

“We will have this kind of idea where sensors will allow us to not only have the ability to test on reconstructed skin but also have the … sensory reality feedback, which is what happens when you apply products and all that, so that we can get assessment of not only the efficacy but also the sensory feedback,” Balooch said.

AI assistant for beauty tips

As well as investing into dermatological tech, L’Oreal also showed off innovations around artificial intelligence at France’s massive tech show last week.

At its booth, the company demonstrated an AI-powered beauty assistant called “BeautyGenius.” The app scans a user’s face to identify their facial features.

It then provides the user with a facial analysis, followed by recommendations of products that suit their skin best. It is powered by generative AI, the same technology that powers OpenAI’s ChatGPT chatbot.

L’Oreal also unveiled an AI marketing lab called CREAITECH, which includes tools that allow it to create brand-compliant, AI-generated marketing content.

L’Oreal is incorporating AI-assisted marketing across its 37 beauty brands, which include Kiehl’s, Lancome, and Giorgio Armani Beauty, and Yves Saint Laurent Beauté, according to the firm.



Source

Healthy Returns: What to know about a CDC vaccine panel’s votes against a mercury preservative in flu shots
Health

Healthy Returns: What to know about a CDC vaccine panel’s votes against a mercury preservative in flu shots

Biostatistician and epidemiologist Martin Kulldorff, MD, PhD, and Dr. Mina Zadeh, ACIP Executive Secretary, CDC, look on as people present their information to members of the Advisory Committee on Immunization Practices, as the U.S. Centers for Disease Control and Prevention’s (CDC) advisory panel for vaccines convenes, in Atlanta, Georgia, U.S. June 25, 2025. Megan Varner […]

Read More
Medicaid cuts in Trump’s ‘big beautiful’ bill will leave millions uninsured, threaten rural hospitals
Health

Medicaid cuts in Trump’s ‘big beautiful’ bill will leave millions uninsured, threaten rural hospitals

An aerial view of Valley Health Hampshire Memorial Hospital on June 17, 2025 in Romney, W.V. Ricky Carioti | The Washington Post | Getty Images President Donald Trump’s “big, beautiful bill” would make sweeping changes to U.S. health care, leaving millions of vulnerable Americans without health insurance and threatening the hospitals and centers that provide […]

Read More
Moderna’s flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
Health

Moderna’s flu vaccine shows positive late-stage trial results, paving way for combination Covid shot

The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and the company’s separate combination flu and […]

Read More